• Fri news: Pfizer’s $1B Chinese commitment. RFK Jr. and pharma. Eisai dials back Leqembi forecast. US diabetes burden increase. JNJ gets Varipulse approval. See more on our front page

Alligator pancreatic cancer drug 'nearly doubles' survival

cafead

Administrator
Staff member
  • cafead   Nov 06, 2024 at 11:42: AM
via Alligator Bioscience has reported updated results with its CD40 agonist mitazalimab as a first-line treatment for advanced pancreatic cancer, a disease with few treatment options.

article source